Glaser Paul E A, Surgener Stewart P, Grondin Richard, Gash C R, Palmer Mike, Castellanos F Xavier, Gerhardt Greg A
Department of Psychiatry, University of Kentucky Chandler Medical Center, Lexington, 40536, USA.
J Neurosci Methods. 2006 Feb 15;151(1):62-7. doi: 10.1016/j.jneumeth.2005.09.019. Epub 2006 Jan 31.
Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) have smaller cerebellar volumes, particularly in the posterior-inferior cerebellar vermis (lobules VIII-X). Functional activation of the human cerebellar vermis following stimulant administration has also been repeatedly demonstrated. There is no well-characterized dopaminergic pathway that projects to the posterior-inferior cerebellar vermis, although the dopamine transporter (DAT) and tyrosine hydroxylase (TH) have been localized in the posterior-inferior vermis in the non-human primate by immunohistochemistry. We hypothesized that DA neurotransmission may occur in localized "hot spots" in the cerebellar vermis, and if so, that differences in such neurotransmission might be relevant to the pathophysiology of ADHD. To investigate this hypothesis, cerebellar tissue was obtained from rats and non-human primates. Catecholamines were extracted and analyzed using HPLC with coulometric detection. A regional gradient of norepinephrine (NE) and DA was found throughout the cerebellum with NE levels always roughly 10-40-fold higher than DA in both rats and monkeys. In addition, in vivo microdialysis studies were performed in the rat posterior-inferior cerebellar vermis in anesthetized animals. Significant NE overflow was observed over baseline following reverse microdialysis induced release by potassium or d-amphetamine. DA overflow was not observed over baseline for potassium stimulation, but was significant for d-amphetamine stimulation. These studies refute the hypothesis that DA neurotransmission normally occurs in the rat cerebellar vermis, but highlight that vermal DA is released by d-amphetamine. The presence of DAT may therefore allow for enhanced regulation of NE and not regulation of released DA.
患有注意力缺陷多动障碍(ADHD)的儿童和青少年小脑体积较小,尤其是小脑后下蚓部(小叶VIII - X)。兴奋剂给药后人小脑蚓部的功能激活也已得到反复证实。虽然通过免疫组织化学在非人灵长类动物的小脑后下蚓部已定位多巴胺转运体(DAT)和酪氨酸羟化酶(TH),但尚无特征明确的多巴胺能通路投射至小脑后下蚓部。我们推测多巴胺神经传递可能发生在小脑蚓部的局部“热点”,如果是这样,这种神经传递的差异可能与ADHD的病理生理学相关。为了研究这一假设,从小鼠和非人灵长类动物获取了小脑组织。使用带电量检测的高效液相色谱法提取并分析儿茶酚胺。在大鼠和猴子的整个小脑中均发现去甲肾上腺素(NE)和多巴胺(DA)存在区域梯度,其中NE水平始终比DA高约10 - 40倍。此外,在麻醉动物的大鼠小脑后下蚓部进行了体内微透析研究。在通过钾或右旋苯丙胺诱导的反向微透析释放后,观察到NE的溢出显著高于基线。对于钾刺激,未观察到DA的溢出高于基线,但对于右旋苯丙胺刺激,DA的溢出显著。这些研究反驳了多巴胺神经传递正常发生在大鼠小脑蚓部的假设,但突出了蚓部多巴胺由右旋苯丙胺释放。因此,DAT的存在可能允许对NE进行增强调节,而不是对释放的多巴胺进行调节。